IDEAYA Biosciences, Inc. - Common Stock (NQ:IDYA)

34.02 -0.24 (-0.70%)

Delayed Quote Updated: 11:16 AM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about IDEAYA Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

IDEAYA Biosciences Highlights 'Encouraging' Preliminary Efficacy, Safety Profile For Patients With Hard-To-Treat Cancer ↗

July 08, 2024

IDEAYA Biosciences reports promising Phase 2 clinical data for IDE397 in MTAP-deletion urothelial and NSCLC patients. The study shows a 39% overall response rate, 94% disease control rate, and a...

Via Benzinga

Corning Increases Sales Forecast, Joins Morphic Holding, Lucid Group And Other Big Stocks Moving Higher On Monday ↗

July 08, 2024

Via Benzinga

Why Ideaya Biosciences Just Made Its Most Bullish Move Since March ↗

July 08, 2024

The company is working on a treatment for cancers tied to a genetic alteration called MTAP deletion.

Via Investor's Business Daily

Why Paramount Global Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

July 08, 2024

Via Benzinga

Unveiling 5 Analyst Insights On IDEAYA Biosciences ↗

May 08, 2024

Via Benzinga

Demystifying IDEAYA Biosciences: Insights From 6 Analyst Reviews ↗

March 08, 2024

Via Benzinga

The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 6 Experts ↗

February 21, 2024

Via Benzinga

IDYA Stock Earnings: IDEAYA Biosciences Misses EPS for Q1 2024 ↗

May 07, 2024

IDYA stock results show that IDEAYA Biosciences missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Recap: IDEAYA Biosciences Q4 Earnings ↗

February 20, 2024

Via Benzinga

The Analyst Verdict: IDEAYA Biosciences In The Eyes Of 8 Experts ↗

January 26, 2024

Via Benzinga

Goldman Sachs Maintains Buy Rating for IDEAYA Biosciences: Here's What You Need To Know ↗

January 25, 2024

Via Benzinga

IDEAYA Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 1/24

January 24, 2024

Via Investor Brand Network

IDEAYA Biosciences Inc. (NASDAQ: IDYA) is a Stock Spotlight on 1/19

January 19, 2024

Via Investor Brand Network

Chart Of The Day: IDEAYA Biosciences - Oncology Biomedicine ↗

January 11, 2024

IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using...

Via Talk Markets

Critical Insights From IDEAYA Biosciences Analyst Ratings: What You Need To Know ↗

January 10, 2024

Via Benzinga

8 Analysts Have This to Say About IDEAYA Biosciences ↗

November 30, 2023

Via Benzinga

The Latest Analyst Ratings for IDEAYA Biosciences ↗

November 13, 2023

Via Benzinga

Why Owens Corning Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

October 25, 2023

Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.

Via Benzinga

Why Ideaya Biosciences Stock Is Plummeting Today ↗

October 25, 2023

Ideaya stock is getting hit hard following a recent press release from the company.

Via The Motley Fool

Where IDEAYA Biosciences Stands With Analysts ↗

October 11, 2023

Via Benzinga

7 Analysts Have This to Say About IDEAYA Biosciences ↗

September 12, 2023

Via Benzinga

The Latest Analyst Ratings for IDEAYA Biosciences ↗

August 11, 2023

Via Benzinga

Why IDEAYA Biosciences Stock Is Falling During Wednesday's Session ↗

October 25, 2023

Ideaya Biosciences Inc (NASDAQ: IDYA) shares are trading lower by 11.6% to $24.10 Wednesday morning after the company priced an underwritten public offering of common stock and pre-funded warrants.

Via Benzinga

Alphabet, Texas Instruments, CoStar Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

October 25, 2023

U.S. stock futures traded mixed this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Adobe To Rally Over 14%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

September 12, 2023

RBC Capital boosted the price target for CareTrust REIT, Inc. (NYSE: CTRE) from $19 to $23. RBC Capital analyst Michael Carroll upgraded the stock from Sector Perform to Outperform. CareTrust REIT...

Via Benzinga

Top 5 Health Care Stocks That May Fall Off A Cliff ↗

September 06, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Akamai Technologies, Array Technologies Music, HNI, PENN Entertainment And Other Big Stocks Moving Higher On Wednesday ↗

August 09, 2023

U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023 ↗

August 08, 2023

Via Benzinga

Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter ↗

June 06, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2023 ↗

May 24, 2023

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.